CARMEL HEINSOHN: Open Payments
NPI 1558328716 · BROOKLINE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,079 in 10 payments from 4 companies in 2025. Trend: 2023 $232 · 2024 $503 · 2025 $1,079
Food & beverage: $1,049Travel & lodging: $30
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $615 |
| Neurocrine BioSciences, Inc. | 3 | $319 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $126 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
Products named: COBENFY, CAPLYTA, INGREZZA, UZEDY.
Industry payments across MA — which companies pay providers there.
